ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation.

Puyu Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.